502 related articles for article (PubMed ID: 33989336)
1. Adherence to cardiovascular pharmacotherapy by patients in Iraq: A mixed methods assessment using quantitative dried blood spot analysis and the 8-item Morisky Medication Adherence Scale.
Alalaqi A; Lawson G; Obaid Y; Tanna S
PLoS One; 2021; 16(5):e0251115. PubMed ID: 33989336
[TBL] [Abstract][Full Text] [Related]
2. Utilizing quantitative dried blood spot analysis to objectively assess adherence to cardiovascular pharmacotherapy among patients at Kenyatta National Hospital, Nairobi, Kenya.
Wata D; Ogwu J; Dunford L; Lawson G; Tanna S
PLoS One; 2023; 18(1):e0280137. PubMed ID: 36662714
[TBL] [Abstract][Full Text] [Related]
3. Association of Changes in Medication Use and Adherence With Accountable Care Organization Exposure in Patients With Cardiovascular Disease or Diabetes.
McWilliams JM; Najafzadeh M; Shrank WH; Polinski JM
JAMA Cardiol; 2017 Sep; 2(9):1019-1023. PubMed ID: 28700790
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Pharmacy Refill Data With Chemical Adherence Testing in Assessing Medication Nonadherence in a Safety Net Hospital Setting.
Osula D; Wu B; Schesing K; Das SR; Moss E; Alvarez K; Clark C; Halm EA; Brown NJ; Vongpatanasin W
J Am Heart Assoc; 2022 Oct; 11(19):e027099. PubMed ID: 36193931
[TBL] [Abstract][Full Text] [Related]
5. Bisoprolol, ramipril and simvastatin determination in dried blood spot samples using LC-HRMS for assessing medication adherence.
Lawson G; Cocks E; Tanna S
J Pharm Biomed Anal; 2013; 81-82():99-107. PubMed ID: 23648556
[TBL] [Abstract][Full Text] [Related]
6. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
[TBL] [Abstract][Full Text] [Related]
7. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Osteoporosis-specific Morisky Medication Adherence Scale in postmenopausal women with osteoporosis newly treated with bisphosphonates.
Reynolds K; Viswanathan HN; O'Malley CD; Muntner P; Harrison TN; Cheetham TC; Hsu JW; Gold DT; Silverman S; Grauer A; Morisky DE
Ann Pharmacother; 2012 May; 46(5):659-70. PubMed ID: 22510666
[TBL] [Abstract][Full Text] [Related]
9. Optimizing prevention and guideline-concordant care in Montenegro.
Knežević B; Musić L; Batrićević G; Bošković A; Bulatović N; Nenezić A; Vujović J; Kalezić M
Int J Cardiol; 2016 Aug; 217 Suppl():S32-6. PubMed ID: 27381861
[TBL] [Abstract][Full Text] [Related]
10. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
[TBL] [Abstract][Full Text] [Related]
11. Optimal pharmacological treatment and adherence to medication in secondary prevention of cardiovascular events in Spain: Results from the CAPS study.
Cordero A; Rodriguez Padial L; Batalla A; López Barreiro L; Torres Calvo F; Castellano JM; Ruiz E; Bertomeu-Martínez V;
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 27957818
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of preventive cardiovascular pharmacotherapy after coronary artery bypass graft surgery.
Barry AR; Koshman SL; Norris CM; Ross DB; Pearson GJ
Pharmacotherapy; 2014 May; 34(5):464-72. PubMed ID: 24877186
[TBL] [Abstract][Full Text] [Related]
13. Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study.
Mathews R; Wang TY; Honeycutt E; Henry TD; Zettler M; Chang M; Fonarow GC; Peterson ED;
Am Heart J; 2015 Jul; 170(1):62-9. PubMed ID: 26093865
[TBL] [Abstract][Full Text] [Related]
14. Self-reported Morisky score for identifying nonadherence with cardiovascular medications.
Shalansky SJ; Levy AR; Ignaszewski AP
Ann Pharmacother; 2004 Sep; 38(9):1363-8. PubMed ID: 15238622
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Medication Management and Medication Adherence for Chronic Conditions.
Brummel A; Carlson AM
J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052
[TBL] [Abstract][Full Text] [Related]
16. Predictors of adherence to composite therapy after acute coronary syndromes.
Stabile E; Franzese M; Chianese S; Alfani A; Gerardi D; Colaiori I; Annunziata M; Nappi P; Scalise M; Di Serafino L; Puzone B; Avvedimento M; Leone A; Ilardi F; Piccolo R; Franzone A; Cirillo P; Morisco C; Trimarco B; Esposito G
J Cardiovasc Med (Hagerstown); 2021 Aug; 22(8):645-651. PubMed ID: 33966020
[TBL] [Abstract][Full Text] [Related]
17. Adherence to common cardiovascular medications in patients with schizophrenia vs. patients without psychiatric illness.
Owen-Smith A; Stewart C; Green C; Ahmedani BK; Waitzfelder BE; Rossom R; Copeland LA; Simon GE
Gen Hosp Psychiatry; 2016; 38():9-14. PubMed ID: 26423559
[TBL] [Abstract][Full Text] [Related]
18. The implications of therapeutic complexity on adherence to cardiovascular medications.
Choudhry NK; Fischer MA; Avorn J; Liberman JN; Schneeweiss S; Pakes J; Brennan TA; Shrank WH
Arch Intern Med; 2011 May; 171(9):814-22. PubMed ID: 21555659
[TBL] [Abstract][Full Text] [Related]
19. Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.
Bermingham M; Hayden J; Dawkins I; Miwa S; Gibson D; McDonald K; Ledwidge M
Clin Ther; 2011 Sep; 33(9):1180-9. PubMed ID: 21840055
[TBL] [Abstract][Full Text] [Related]
20. Identifying adherent patients to newly initiated statins using previous adherence to chronic medications.
Majd Z; Mohan A; Paranjpe R; Abughosh SM
J Manag Care Spec Pharm; 2021 Feb; 27(2):186-197. PubMed ID: 33506725
[No Abstract] [Full Text] [Related]
[Next] [New Search]
